Bottom line
XLV vs TRUH: the short answer
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and TRUH (VanEck Healthcare TruSector ETF) have nearly the same top holdings — their top 25 positions are about 100% the same by weight.
XLV is cheaper at 0.08% vs 0.1% — a difference of $2.00 a year per $10,000 invested.
Updated Nov 19, 2026
XLV vs TRUH side by side
| XLV | TRUH | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | VanEck |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.08% | 0.1% |
| Annual cost per $10k | $8 | $10 |
| 10-yr cost on $10k (prospectus) | $103 | — |
| Max front load | None | None |
| 12b-1 fee | 0.02% | — |
| 1-yr return | +14.5% | — |
| 5-yr return (annualized) | +8.1% | — |
| 10-yr return (annualized) | +9.8% | — |
| Best quarter | +14.5% | — |
| Worst quarter | −12.7% | — |
| Net assets (fund) | $40.6B | $833.1K |
| Number of holdings | 65 | 60 |
| Portfolio turnover | 2% | — |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
25 of XLV's top 25 holdings also appear in TRUH's top 25.
| Holding | XLV | TRUH |
|---|---|---|
| Eli Lilly & Co | 16.51% | 16.56% |
| Johnson & Johnson | 10.64% | 10.67% |
| AbbVie Inc | 7.74% | 7.76% |
| UnitedHealth Group Inc | 6.57% | 6.59% |
| Merck & Co Inc | 5.52% | 5.54% |
| Amgen Inc | 3.40% | 3.39% |
| Thermo Fisher Scientific Inc | 3.24% | 3.25% |
| Abbott Laboratories | 2.75% | 2.76% |
| Gilead Sciences Inc | 2.73% | 2.74% |
| Intuitive Surgical Inc | 2.45% | 2.48% |
| Pfizer Inc | 2.39% | 2.40% |
| CVS Health Corp | 2.30% | 2.31% |
| Vertex Pharmaceuticals Inc | 2.19% | 2.21% |
| Danaher Corp | 2.09% | 2.10% |
| Bristol-Myers Squibb Co | 2.05% | 2.05% |
Source: SEC Form N-PORT
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
TRUH top 10
- Eli Lilly & Co — 16.56%
- Johnson & Johnson — 10.67%
- AbbVie Inc — 7.76%
- UnitedHealth Group Inc — 6.59%
- Merck & Co Inc — 5.54%
- Amgen Inc — 3.39%
- Thermo Fisher Scientific Inc — 3.25%
- Abbott Laboratories — 2.76%
- Gilead Sciences Inc — 2.74%
- Intuitive Surgical Inc — 2.48%
FAQ
What is the difference between XLV and TRUH?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and TRUH (VanEck Healthcare TruSector ETF) have nearly the same top holdings — their top 25 positions are about 100% the same by weight. XLV is cheaper at 0.08% vs 0.1% — a difference of $2.00 a year per $10,000 invested.
Which is cheaper, XLV or TRUH?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and TRUH?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.